188 related articles for article (PubMed ID: 23928914)
1. The EGAPP initiative: lessons learned.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2014 Mar; 16(3):217-24. PubMed ID: 23928914
[TBL] [Abstract][Full Text] [Related]
2. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Teutsch SM; Bradley LA; Palomaki GE; Haddow JE; Piper M; Calonge N; Dotson WD; Douglas MP; Berg AO;
Genet Med; 2009 Jan; 11(1):3-14. PubMed ID: 18813139
[TBL] [Abstract][Full Text] [Related]
3. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2007 Dec; 9(12):819-25. PubMed ID: 18091431
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of interest in evidence-based evaluations of genetic tests.
Botkin JR; Teutsch SM; Kaye CI; Hayes M; Haddow JE; Bradley LA; Szegda K; Dotson WD;
Genet Med; 2010 Apr; 12(4):228-35. PubMed ID: 20118789
[TBL] [Abstract][Full Text] [Related]
5. Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.
Veenstra DL; Piper M; Haddow JE; Pauker SG; Klein R; Richards CS; Tunis SR; Djulbegovic B; Marrone M; Lin JS; Berg AO; Calonge N
Genet Med; 2013 Jan; 15(1):14-24. PubMed ID: 22955111
[TBL] [Abstract][Full Text] [Related]
6. The clinical implementation of whole genome sequencing: a conversation with seven scientific experts.
Lerner-Ellis JP
J Inherit Metab Dis; 2012 Jul; 35(4):689-93. PubMed ID: 22403015
[TBL] [Abstract][Full Text] [Related]
7. Public health genomics: translating obesity genomics research into population health benefits.
Agurs-Collins T; Khoury MJ; Simon-Morton D; Olster DH; Harris JR; Milner JA
Obesity (Silver Spring); 2008 Dec; 16 Suppl 3(Suppl 3):S85-94. PubMed ID: 19037221
[TBL] [Abstract][Full Text] [Related]
8. The impact of genomics on public health practice: the case for change.
Zimmern RL; Khoury MJ
Public Health Genomics; 2012; 15(3-4):118-24. PubMed ID: 22488453
[TBL] [Abstract][Full Text] [Related]
9. An overview of recommendations and translational milestones for genomic tests in cancer.
Chang CQ; Tingle SR; Filipski KK; Khoury MJ; Lam TK; Schully SD; Ioannidis JP
Genet Med; 2015 Jun; 17(6):431-40. PubMed ID: 25341115
[TBL] [Abstract][Full Text] [Related]
10. Genomics for disease treatment and prevention.
Bloss CS; Jeste DV; Schork NJ
Psychiatr Clin North Am; 2011 Mar; 34(1):147-66. PubMed ID: 21333845
[TBL] [Abstract][Full Text] [Related]
11. Predictive genetic testing for complex diseases: a public health perspective.
Marzuillo C; De Vito C; D'Andrea E; Rosso A; Villari P
QJM; 2014 Feb; 107(2):93-7. PubMed ID: 24049051
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.
Esmail LC; Roth J; Rangarao S; Carlson JJ; Thariani R; Ramsey SD; Veenstra DL; Deverka P
Genet Med; 2013 Feb; 15(2):115-22. PubMed ID: 23037935
[TBL] [Abstract][Full Text] [Related]
14. Proposed outcomes measures for state public health genomic programs.
Doyle DL; Clyne M; Rodriguez JL; Cragun DL; Senier L; Hurst G; Chan K; Chambers DA
Genet Med; 2018 Sep; 20(9):995-1003. PubMed ID: 29300382
[TBL] [Abstract][Full Text] [Related]
15. Realizing the potential of genomics: translation is not translational research.
Zimmern RL; Brice PC
Genet Med; 2009 Dec; 11(12):898-9; author reply 899. PubMed ID: 20010367
[No Abstract] [Full Text] [Related]
16. Translating evidence into population health improvement: strategies and barriers.
Woolf SH; Purnell JQ; Simon SM; Zimmerman EB; Camberos GJ; Haley A; Fields RP
Annu Rev Public Health; 2015 Mar; 36():463-82. PubMed ID: 25581146
[TBL] [Abstract][Full Text] [Related]
17. Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2014 Apr; 16(4):338-46. PubMed ID: 24071797
[TBL] [Abstract][Full Text] [Related]
18. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
20. Reconciling Opportunistic and Population Screening in Clinical Genomics.
Brothers KB; Vassy JL; Green RC
Mayo Clin Proc; 2019 Jan; 94(1):103-109. PubMed ID: 30611438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
